Next report date
Report period
Q2 2024
EPS estimate
1.58CHF
Revenue estimate
664.00 MCHF
6.925CHF
499.60 MCHF
2.48 BCHF
72.44 M
About West Pharmaceutical Services, Inc.
Sector
Industry
CEO
Eric Mark Green
Website
Headquarters
Exton
Employees (FY)
10.6 K
Founded
1923
FIGI
BBG00LVGJRP6
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of WPS is 344.740 CHF — it has increased by 2.97% in the past 24 hours. Watch WEST PHARMACEUTICA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange WEST PHARMACEUTICA stocks are traded under the ticker WPS.
WEST PHARMACEUTICA is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
WPS stock is 2.88% volatile and has beta coefficient of 1.15. Track WEST PHARMACEUTICA stock price on the chart and check out the list of the most volatile stocks — is WEST PHARMACEUTICA there?
WPS earnings for the last quarter are 1.54 CHF per share, whereas the estimation was 1.50 CHF resulting in a 2.91% surprise. The estimated earnings for the next quarter are 1.15 CHF per share. See more details about WEST PHARMACEUTICA earnings.
WEST PHARMACEUTICA revenue for the last quarter amounts to 616.30 M CHF despite the estimated figure of 622.58 M CHF. In the next quarter revenue is expected to reach 604.98 M CHF.
Yes, you can track WEST PHARMACEUTICA financials in yearly and quarterly reports right on TradingView.
WPS stock has risen by 2.97% compared to the previous week, the month change is a 2.97% rise, over the last year WEST PHARMACEUTICA has showed a 10.12% increase.
WPS net income for the last quarter is 104.01 M CHF, while the quarter before that showed 115.35 M CHF of net income which accounts for −9.82% change. Track more WEST PHARMACEUTICA financial stats to get the full picture.
Today WEST PHARMACEUTICA has the market capitalization of 24.23 B, it has decreased by 1.19% over the last week.
Yes, WPS dividends are paid quarterly. The last dividend per share was 0.18 CHF. As of today, Dividend Yield (TTM)% is 0.22%. Tracking WEST PHARMACEUTICA dividends might help you take more informed decisions.
WEST PHARMACEUTICA dividend yield was 0.22% in 2023, and payout ratio reached 9.90%. The year before the numbers were 0.31% and 9.57% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, WPS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WEST PHARMACEUTICA stock right from TradingView charts — choose your broker and connect to your account.
As of May 5, 2024, the company has 10.60 K employees. See our rating of the largest employees — is WEST PHARMACEUTICA on this list?
We've gathered analysts' opinions on WEST PHARMACEUTICA future price: according to them, WPS price has a max estimate of 431.56 CHF and a min estimate of 325.96 CHF. Watch WPS chart and read a more detailed WEST PHARMACEUTICA stock forecast: see what analysts think of WEST PHARMACEUTICA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WEST PHARMACEUTICA EBITDA is 737.30 M CHF, and current EBITDA margin is 28.74%. See more stats in WEST PHARMACEUTICA financial statements.